Weekly Charts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Syngene International Ltd, a pharma stock, fell 15% from its September 2023 high but recovered after a Double Bottom formation. Short-term traders can buy the stock for a target of Rs 880 in the next 2 months. The stock found support above 670 levels in October and December 2023, forming a Double Bottom. It closed above the 50-week moving average in January 2024. The stock is now trading above multiple moving averages and the RSI is at 56.5, indicating bullishness.

According to a new report, the world’s primary recipient of Ukrainian grain is China, and the pace of exports has exceeded pre-war levels. But the Chinese leader’s long game goes much further.

Follow @MrTopStep and @BretKenwell on Twitter and please share if you find our work valuable.Our ViewKeeping things short and simple for the View. The market continues to slowly trickle lower. Surprisingly, it’s frustrating both sides. The bulls are frustrated for obvious reasons: They are looking for a bounce that simply hasn’t materialized, as the S&P is

Follow @MrTopStep and @BretKenwell on Twitter and please share if you find our work valuable.Our ViewInterest rates are on the rise. Or at least, that’s the expectation. To quickly recap the last four weeks, the January jobs report came in stunningly hot (more than double economists’ expectations). Then the CPI, PPI and PCE reports all

Follow @MrTopStep and @BretKenwell on Twitter and please share if you find our work valuable.Our ViewAfter a solid rebound on Thursday, the ES posted its worst week of the year. The ES and NQ were weak going into January's PCE reading, which overshot economists’ expectations. We have written it 9 other times this month, but